As a global medtech powerhouse, Getinge is set to reinforce its presence in the Indian market via the India Innovation Centre (IIC) and strategic partnerships with industry and academia, catering to a global audience. The company holds a substantial market share in India in various product categories, such as ventilators (30%), heart-lung machines (50%), intra-aortic balloon pumps (70%), extracorporeal membrane oxygenation (ECMO) (90%), and operating room tables (25%).
Getinge India Pvt. Ltd.’s Managing Director, Aruna Nayak, highlighted the company’s role in India’s healthcare sector progress, particularly during the COVID-19 pandemic. Getinge supported healthcare professionals by executing a record number of advanced ventilator installations and supplying ECMO products. Their service engineers also managed around 10,000 service calls pertaining to these products.
According to Nayak, India is now among Getinge’s top 10 markets worldwide, and the company is partnering with 10,000 Indian hospitals to develop a world-class infrastructure. Getinge is dedicated to not only introducing high-end technologies and devices to India, but also manufacturing them locally and making them available in the US and European Union. The company is well-positioned to cater to the Indian market with its high-quality products as healthcare infrastructure investments surge.
As part of their Indian expansion plan, Getinge launched an Innovation Centre in Bangalore in January 2020, with a focus on devising advanced and economically viable solutions for emergency critical care and clinical trials. Additionally, Getinge has teamed up with IIT Bombay’s School of Biomedical Engineering to develop inventive and cost-effective emergency critical care solutions, drawing on lessons learned from the pandemic.
